Experienced in Rubella

Mercedes Parra-Macias

Mexico City, DIF, MX 
Experienced in Rubella
Mexico City, DIF, MX 
OverviewLocationsClinical Research

Overview

Mercedes Parra-Macias practices in Mexico City, Mexico. Ms. Parra-Macias is rated as an Experienced expert by MediFind in the treatment of Rubella. Her top areas of expertise are Chickenpox, Intussusception in Children, Togaviridae Disease, and Otitis.

Her clinical research consists of co-authoring 22 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Rubella.

Gender
Female

Locations

Mexico City, DIF, Mexico
Other Locations
Paso Nacional, OAX, Mexico
Mexico, MEX, Mexico
Av. Insurgentes Sur 3700-C Insurgentes Cuicuilco, Insurgentes Cuicuilco, DIF 04530, Mexico
Guanajuato, GUA, Mexico
Insurgentes Cuicuilco, CP 04530, Coyoacan, DIF 04530, Mexico

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in Infants
A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in Infants
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Biological, Drug
Study Phase: Phase 1/Phase 2

22 Total Publications

SNPs at the IL-2, IL-12, TNF-α and TGF-β1 regulatory gene regions are probably important for Toxoplasma gondii congenital transmission and disease severity in humans.
SNPs at the IL-2, IL-12, TNF-α and TGF-β1 regulatory gene regions are probably important for Toxoplasma gondii congenital transmission and disease severity in humans.
Journal: Microbes and infection
Published: May 08, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Parra-Macias's expertise for a condition
ConditionClose
        View All 13 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile